Retroviruslar ve Onkojenik Mekanizması
Synopsis
Retroviruslar, RNA genomlarını DNA’ya dönüştürerek konak hücre genomuna entegre olabilen zarflı yapıdaki viruslardır. Entegrasyon yetenekleri, kalıcı enfeksiyonlar ve hücresel transformasyonlara yol açabilir. Hücre içi çoğalma mekanizmalarını manipüle edebilen retroviruslar, gen düzenlenmesinde değişikliklere sebep olarak hücresel proliferasyonu ve tümör gelişimini tetikleyebilmektedirler. İnsan kanserlerinin %20’si ve hayvanlarda görülen bazı tümörler, retrovirusların onkojenik etkisiyle ilişkilendirilmiştir. Retrovirusların yüksek mutasyon oranı ve konak genomuna entegrasyon yetenekleri, antiviral tedavi ve aşı geliştirme çalışmalarını da zorlaştırmaktadır. Bu virusların genetik çeşitliliği, immun sistem hücrelerinin asıl hedefi olan antijenik yapıların değişkenliğine sebebiyet vererek etkili bağışıklık yanıtı oluşmasını engeller. Ayrıca, farklı retrovirus türleri ve coğrafi varyasyonlar, tüm varyantlara karşı etkili tek bir aşı formülasyonu geliştirilmesini zorlaştırmaktadır.
Gelecekte retroviral hastalıklarla mücadele amacıyla bu virusların moleküler mekanizmalarının daha iyi anlaşılması, yeni antiviral ilaçların ve genetik tabanlı tedavilerin geliştirilmesi kritik öneme sahiptir. Yapılacak geniş kapsamlı seroprevalans çalışmaları ve uygulanacak enfeksiyon kontrol önlemleri, retroviral enfeksiyonların yayılmasını sınırlamada önemli rol oynayabilir. Retrovirusların biyoteknolojik ve genetik araçlarla daha etkin takip edilmesi, enfeksiyonlara karşı mücadelede yeni stratejiler sunabilir.
Retroviruses are enveloped viruses that have the capacity to integrate into the host cell genome by converting their RNA genome into DNA, a process which can lead to persistent infections and cellular transformations. They are capable of manipulating intracellular proliferation mechanisms, thereby triggering cellular proliferation and tumour development by causing changes in gene regulation. It is estimated that approximately 20% of human cancers and some tumours in animals have been associated with the oncogenic effect of retroviruses. The high mutation rate of retroviruses and their ability to integrate into the host genome present significant challenges to antiviral therapy and vaccine development. The genetic diversity of these viruses leads to variability in antigenic structures, which are the primary target of immune system cells, and prevents the formation of an effective immune response.Furthermore, the existence of different retrovirus species and geographical variations complicates the development of a single vaccine formulation effective against all variants.
In order to combat retroviral diseases in the future, it is critical to enhance our understanding of the molecular mechanisms of these viruses and to develop new antiviral drugs and genetic-based therapies. Comprehensive seroprevalence studies and infection control measures have the potential to play an important role in limiting the spread of retroviral infections. The development of more effective monitoring of retroviruses with biotechnological and genetic tools may offer new strategies in the fight against infections.
References
Jaya, M. Cancer History Project. (2023). Cancer as ancient Egyptians knew and understood it. Retrieved from https://cancerhistoryproject.com/article/cancer-as-ancient-egyptians-knew-and-understood-it/
Taylor, S. E. (2010). Cancer: A historical perspective. In S. E. Taylor (Ed.), The Behavioral Basis of Cancer Prevention (pp. 23-45). Springer. https://doi.org/10.1007/978-1-4419-5968-3_3
Vogelstein, B., & Kinzler, K. W. (2015). The genetic basis of human cancer. Science, 339(6124), 1546-1558. https://doi.org/10.1126/science.1235122
DeVita, V. T., Hellman, S., & Rosenberg, S. A. (2015). Cancer: Principles and practice of oncology. Lippincott Williams & Wilkins.
Jakóbisiak, M., Lasek, W., & Gołab, J. (2003). Natural mechanisms protecting against cancer. Immunology letters, 90(2-3), 103–122. https://doi.org/10.1016/j.imlet.2003.08.005
Blackburn, E., Greider, C. & Szostak, J. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 12, 1133–1138 (2006). https://doi.org/10.1038/nm1006-1133
Shay J. W. (2016). Role of Telomeres and Telomerase in Aging and Cancer. Cancer discovery, 6(6), 584–593. https://doi.org/10.1158/2159-8290.CD-16-0062
Flint, J., Racaniello, V. R., Rall, G. F., Hatziioannou, T., & Skalka, A. M. (2020). Principles of virology (5th ed.). Wiley.
Coffin, J. M., Hughes, S. H., & Varmus, H. E. (Eds.). (1997). Retroviruses. Cold Spring Harbor Laboratory Press.
ICTV, International Committee on Taxonomy of Viruses. (2023). Retroviridae. Retrieved from https://ictv.global/report/chapter/retroviridae/retroviridae
Hunter, E., & Swanstrom, R. (1990). Retrovirus envelope glycoproteins. In R. Swanstrom & P. K. Vogt (Eds.), Retroviruses (pp. 91-135). Springer. https://doi.org/10.1007/978-3-642-75218-6_7
McVey, D. S., Kennedy, M., Chengappa, M. M., & Wilkes, R. (Eds.). (2022). Veterinary microbiology (4th ed.). Wiley-Blackwell.
Johnson, S. F., & Telesnitsky, A. (2010). Retroviral RNA dimerization and packaging: The what, how, when, where, and why. PLoS Pathogens, 6(10), e1001007. https://doi.org/10.1371/journal.ppat.1001007
ICTV, International Committee on Taxonomy of Viruses. (2024). Retroviridae. ICTV Report. https://ictv.global/report/chapter/retroviridae/retroviridae
Kemeter, L. M., Birzer, A., Heym, S., & Thoma-Kress, A. K. (2023). Milk Transmission of Mammalian Retroviruses. Microorganisms, 11(7), 1777. https://doi.org/10.3390/microorganisms11071777
Ilina, T. V., Brosenitsch, T., Sluis-Cremer, N., & Ishima, R. (2021). Retroviral RNase H: Structure, mechanism, and inhibition. The Enzymes, 50, 227-247. https://doi.org/10.1016/bs.enz.2021.07.007
Telesnitsky, A., & Goff, S. P. (1997). Reverse transcriptase and the generation of retroviral DNA. In J. M. Coffin, S. H. Hughes, & H. E. Varmus (Eds.), Retroviruses (pp. 121-160). Cold Spring Harbor Laboratory Press. https://www.ncbi.nlm.nih.gov/books/NBK19435/
Bullough, P. A., & Hughson, F. M. (1994). Crystals of a fragment of influenza haemagglutinin in the low pH induced conformation. Journal of Molecular Biology, 236(4), 1262-1265.
Nisole, S., & Saïb, A. (2004). Early steps of retrovirus replicative cycle. Retrovirology, 1(1), 9. https://doi.org/10.1186/1742-4690-1-9
Chameettachal, A., Mustafa, F., & Rizvi, T. A. (2023). Understanding Retroviral Life Cycle and its Genomic RNA Packaging. Journal of molecular biology, 435(3), 167924. https://doi.org/10.1016/j.jmb.2022.167924
Hu, W. S., & Temin, H. M. (1990). Retroviral recombination and reverse transcription. Science, 250(4985), 1227-1233. https://doi.org/10.1126/science.2255909
Craigie R. (2001). HIV integrase, a brief overview from chemistry to therapeutics. The Journal of biological chemistry, 276(26), 23213–23216. https://doi.org/10.1074/jbc.R100027200
Hughes, S. H., & Coffin, J. M. (2016). What Integration Sites Tell Us about HIV Persistence. Cell host & microbe, 19(5), 588–598. https://doi.org/10.1016/j.chom.2016.04.010
University of Texas at Arlington. (2010, January 8). Evolutionary surprise: Eight percent of human genetic material comes from a virus. ScienceDaily. Retrieved August 23, 2024, from www.sciencedaily.com/releases/2010/01/100107103621.htm
Köppke, J., Keller, LE., Stuck, M. ve ark. Direct translation of incoming retroviral genomes. Nat Commun 15, 299 (2024). https://doi.org/10.1038/s41467-023-44501-7
Vogt P. K. (2012). Retroviral oncogenes: a historical primer. Nature reviews. Cancer, 12(9), 639–648. https://doi.org/10.1038/nrc3320
Hamilton, D. R. (2013). Cancer: Ancient history. In M. D. Gellman & J. R. Turner (Eds.), Encyclopedia of Behavioral Medicine (pp. 283-285). Springer. https://doi.org/10.1007/978-3-642-16483-5_5917
Hofacre, A., & Fan, H. (2010). Jaagsiekte sheep retrovirus biology and oncogenesis. Viruses, 2(12), 2618–2648. https://doi.org/10.3390/v2122618
Fan, H., & Johnson, C. (2011). Insertional oncogenesis by non-acute retroviruses: implications for gene therapy. Viruses, 3(4), 398–422. https://doi.org/10.3390/v3040398
Bushman F. D. (2020). Retroviral Insertional Mutagenesis in Humans: Evidence for Four Genetic Mechanisms Promoting Expansion of Cell Clones. Molecular therapy: the journal of the American Society of Gene Therapy, 28(2), 352–356. https://doi.org/10.1016/j.ymthe.2019.12.009
Uren, A. G., Kool, J., Berns, A., & van Lohuizen, M. (2005). Retroviral insertional mutagenesis: past, present and future. Oncogene, 24(52), 7656–7672. https://doi.org/10.1038/sj.onc.1209043
Brites, C., Grassi, M. F., Quaresma, J. A. S., Ishak, R., & Vallinoto, A. C. R. (2021). Pathogenesis of HTLV-1 infection and progression biomarkers: An overview. The Brazilian journal of infectious diseases :an official publication of the Brazilian Society of Infectious Diseases, 25(3), 101594. https://doi.org/10.1016/j.bjid.2021.101594
Pryor, K.N., & Marriott, S.J. (2013). Pleiotropic Functions of HTLV-1 Tax Contribute to Cellular Transformation. InTech. https://doi.org/10.5772/54787
Kassiotis G. (2014). Endogenous retroviruses and the development of cancer. Journal of immunology (Baltimore, Md. : 1950), 192(4), 1343–1349. https://doi.org/10.4049/jimmunol.1302972
Nelson, P. N., Carnegie, P. R., Martin, J., Davari Ejtehadi, H., Hooley, P., Roden, D., Rowland-Jones, S., Warren, P., Astley, J., & Murray, P. G. (2003). Demystified. Human endogenous retroviruses. Molecular Pathology: MP, 56(1), 11–18. https://doi.org/10.1136/mp.56.1.11
Nishigaki, K., Hanson, C., Jelacic, T., Thompson, D., & Ruscetti, S. (2005). Friend spleen focus-forming virus transforms rodent fibroblasts in cooperation with a short form of the receptor tyrosine kinase Stk. Proceedings of the National Academy of Sciences of the United States of America, 102(43), 15488–15493. https://doi.org/10.1073/pnas.0506570102
Palmarini, M., Hallwirth, C., York, D., Murgia, C., de Oliveira, T., Spencer, T., & Fan, H. (2000). Molecular cloning and functional analysis of three type D endogenous retroviruses of sheep reveal a different cell tropism from that of the highly related exogenous jaagsiekte sheep retrovirus. Journal of virology, 74(17), 8065–8076. https://doi.org/10.1128/jvi.74.17.8065-8076.2000
Miller A. D. (2008). Hyaluronidase 2 and its intriguing role as a cell-entry receptor for oncogenic sheep retroviruses. Seminars in cancer biology, 18(4), 296–301. https://doi.org/10.1016/j.semcancer.2008.03.010
Yu, D. L., Linnerth-Petrik, N. M., Halbert, C. L., Walsh, S. R., Miller, A. D., & Wootton, S. K. (2011). Jaagsiekte sheep retrovirus and enzootic nasal tumor virus promoters drive gene expression in all airway epithelial cells of mice but only induce tumors in the alveolar region of the lungs. Journal of virology, 85(15), 7535–7545. https://doi.org/10.1128/JVI.00400-11
Walsh, S.R., Linnerth-Petrik, N.M., Yu, D.L. ve ark. (2013). Experimental transmission of enzootic nasal adenocarcinoma in sheep. Veterinary Research 44, 66. https://doi.org/10.1186/1297-9716-44-66
Maeda, N., Inoshima, Y., De las Heras, M. ve ark. Enzootic nasal tumor virus type 2 envelope of goats acts as a retroviral oncogene in cell transformation. Virus Genes 57, 50–59 (2021). https://doi.org/10.1007/s11262-020-01808-7
Leroux, C., Girard, N., Cottin, V., Greenland, T., Mornex, J. F., & Archer, F. (2007). Jaagsiekte Sheep Retrovirus (JSRV): from virus to lung cancer in sheep. Veterinary research, 38(2), 211–228. https://doi.org/10.1051/vetres:2006060
